Schedule of Events
Friday, April 25, 2014
7:00AM - 8:00AM
Pharmacy Transitions of Care Services - Successes, Failures, and Lesson Learned
This program will focus on sharing our personal experiences with providing inpatient pharmacy transition of care services. Included will be an overview of our ASHP-APhA Best Practice Award winning program and culmination of nearly 3 years of data. This program will integrate an analysis of our successes and failures with some of the resultant lessons learned. Additionally patient cases will be utilized to highlight specific transition of care pearls. Ultimately our goal is to provide some insight that others may consider when developing similar programs within their pharmacy practice.
At the completion of this activity, the participant will be able to: 1. Describe the challenges that exist when implementing and staffing a transition of care program. 2. Identify key components of the communication structure that should be considered when developing a transition of care program. 3. Explain the potential benefits of a transition of care program in relation to hospital readmissions and core measure compliance.
Chad Bradford, PharmD, Touro University College of Pharmacy
From Rx Pad to Pill Box: Obstacle to Successful Medication Outcomes in Community-Dwelling Seniors
Determinants of successful medication outcomes start much earlier that the pharmacy counter. Interactions with the health system, prescriber practices, patient health beliefs, health literacy, family/caregiver support and dispensing services all play a role in maximizing patient outcomes. Failure to assess for these confounding issues and consequently incorporate interventions within a safe medication management system puts the patient at risk and impedes achieving maximal outcomes with medication. The pharmacist is positioned to lead the team in safe medication management from prescription pad to pill box.
At the completion of this activity, the participant will be able to: 1. detect patient, health system and treatment-related factors which impede safe medication use in the community. 2. examine the consequences of an unsafe medication system on the community-dwelling older adult 3. formulate interventions that interrupt the sequence of unsafe medication system practices and consequently improve treatment outcomes
Marsha Meyer, PharmD, CGP, CGCM
8:15AM - 9:15AM
Expanding the Reach of EC: Evidence Based Live Education for Clinicians and Pharmacists about Emergency Contraception
ARHP is sponsoring Expanding the Reach of the ABC’s of EC: Evidence Based Live Education for Clinicians and Pharmacists about Emergency Contraception, an education program for health care providers. The goal of this program is to improve providers competence and performance in practice to appropriately discuss Emergency Contraception (EC) with women of reproductive age (and their partners) during routine and emergency visits. In addition, the program will facilitate patients access to EC by providing them with accurate information about how, where and when to get and use EC and/or advanced prescriptions.
Don Downing, RPh, University of Washington, School of Pharmacy
8:15 AM - 9:45AM
Clinical Pharmacy Practice Transformation: Strategies For A New Era
This presentation will focus on specific strategies that the VA has launched over the past 3 years that have resulted in tremendous expansion of clinical pharmacy practices and how these strategies can be used outside the VA to take advantage of the changes whcih will come about as a result of SB 493.
At the completion of this activity, the participant will be able to: 1. Discuss 4 targeted areas in which clinical pharmacy practices in primary and specialty care settings were expanded. 2. Describe 3 strategies the VA has used to enhance competency, and provide oversight with regard to advanced clinical practices. 3. Explore multiple areas of practice outside the VA where these principles can be applied to expand clinical pharmacy practices. 4. Identify 3 changes that can be implemented to make pharmacy practice more innovative regardless of your setting.
Anthony Morreale, PharmD, MBA, BCPS, Clinical Pharmacy Services and Health Services Research, Department of Veterans Affairs
9:30AM - 10:30AM
Why Do We Recommend What We Recommend for Diabetes?
This course will provide pharmacists with a review of the most relevant and significant studies that have been published on diabetes in recent years. By looking at key research papers on diabetes, this session will provide answers to questions like, “Why do we have A1C targets set at 7% for most, <6.5% for some and <8% for others?” and “Why did the American Diabetes Association change the blood pressure goal for patients with diabetes?” The purpose of this course is to improve practitioners’ understanding of evidence based medicine and the reasoning behind the recommendations we give to our patients.
At the completion of this activity, the participant will be able to: 1.Explain why we recommend an A1C of 7% for most, <6.5% for some, and <8% for others 2.Describe why the American Diabetes Association changed the blood pressure goals for patients with diabetes 3.Summarize the changes for aspirin recommendations in primary prevention for patients with diabetes
Jeany Jun, PharmD, MPH, Loma Linda University, School of Pharmacy
How the Medicare Star Ratings will Transform Payment Models in Community Pharmacy
This session will identify the growing importance of the Medicare Star Ratings and other programs for measuring the quality of medication use. These programs have driven changes in the way that health plans and PBMs are evaluated and are now starting to affect the structure of pharmacy networks and the payment models for community pharmacy. The speaker will highlight the implications for community pharmacies and how they should prepare for a new environment of quality-based payment.
At the completion of this activity, the participant will be able to: 1. Describe how the Medicare Star Ratings, state insurance exchanges and pharmacy accreditation programs will drive demand for medication adherence measurement at the pharmacy level. 2. List the Medicare Part D star measures that are triple-weighted by CMS. 3. Identify how community pharmacies can track their performance on Part D star measures. 4. Describe how health plans and pharmacies can collaborate for improvement of medication-use quality.
David Nau, PhD, RPh, CPHQ, Pharmacy Quality Solutions
4:00PM - 6:00PM
New Drug Update 2014
This presentation considers the properties and uses of selected new therapeutic agents. The indications and routes of administration for these new drugs are reviewed, as are the most important precautions and practical considerations regarding their use. Where possible, the properties of the new drugs are compared with those of older drugs marketed for the same indications. A New Drug Comparison Rating (NDCR) is provided for each of the new drugs considered.
At the completion of this activity, the participant will be able to: 1. Identify the indications and routs of administration of the new therapeutic agents that were marketed in 2013. 2. Identify the important pharmacokinetic properties and unique characteristics of the new drugs; Identify the most important adverse events and precautions of the new drugs. 3. Compare the new drugs to the older therapeutic agents to which they are most similar in activity. 4. Identify information regarding the new drugs that should be communicated to patients.
Dan Hussar, PhD, Philadelphia College of Pharmacy
SB493, Immunizations, and You
At the completion of this activity, the participant will be able to: 1. Discuss routine immunizations and current pharmacy law pertaining to their administration in CA 2. Discuss how SB 493 will facilitate pharmacist provided immunizations 3. Discuss how to implement a pharmacist provided immunization service under SB 493.
Karl Hess, PharmD, Western University of Health Science, College of Pharmacy
Jeff Goad, PharmD, MPH, USC School of Pharmacy
MTM - Mastering The Method
Because of the passage of SB 493 and the Affordable Care Act (ACA), medication therapy management service (MTM) becomes more important to pharmacy practice. This program will: 1. Review the MTM fundamentals 2. Discuss implementation of MTM pharmacy services 3. Present data supporting the justification of MTM services by pharmacists 4. Examine the importance of implementing MTM pharmacy service because of the ACA 5. Provide resources and references available to the practitioner Throughout the presentation, participants will be asked discussion questions related to MTM and their practice of pharmacy. The program is targeted to pharmacists, pharmacy managers, students and residents.
At the completion of this activity, the participant will be able to: 1. Describe MTM and its core elements 2. Why MTM needs to be implemented in their practice. 3. List organizations providing MTM resources and references available to implement and support MTM services 4. Discuss how MTM aligns with the objectives of health care reform 5. Promote MTM services to the public, legislators and administrators.
Brian Kawahara, PharmD, M.M., FASHP
Rebecca Cupp, RPh, Ralphs Grocery Company
Edith Mirzaian, PharmD, USC School of Pharmacy